119 related articles for article (PubMed ID: 78907)
1. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
Harlos JP; Weiss L
Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests.
Shenton BK; Jenssen HL; Werner H; Field EJ
J Immunol Methods; 1977; 14(2):123-39. PubMed ID: 138709
[TBL] [Abstract][Full Text] [Related]
3. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
Fike RM; van Oss CJ
Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
[TBL] [Abstract][Full Text] [Related]
4. On the mechanism of binding of human lymphocyte products to guinea pig macrophages.
Weiss L; Harlos JP; Subjeck JR
Cell Biophys; 1979 Mar; 1(1):65-77. PubMed ID: 95169
[TBL] [Abstract][Full Text] [Related]
5. [Macrophage electrophoretic mobility test (MEM) and tanned erythrocyte electrophoretic mobility test (TEEM) for cancer diagnosis (author's transl)].
Zhao BH; Hu JK; Liang JX
Zhonghua Zhong Liu Za Zhi; 1979; 1(3):195-200. PubMed ID: 553795
[No Abstract] [Full Text] [Related]
6. Electrophoretic mobility test for lymphocyte sensitization using tanned sheep erythrocytes.
Jenssen HL; Shenton BK
Acta Biol Med Ger; 1975; 34(4):K 29-32. PubMed ID: 1237979
[TBL] [Abstract][Full Text] [Related]
7. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
Glaves D; Harlos JP; Weiss L
Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
[TBL] [Abstract][Full Text] [Related]
8. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
9. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
Crozier EH; Hollinger ME; Woodend BE; Robertson JH
J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
[TBL] [Abstract][Full Text] [Related]
11. A reappraisal of the macrophage electrophoretic mobility (MEM) test for the measurement of lymphokine activity.
Brown KA; Wolstencroft RA; Booth CG; Dumonde DC
J Immunol Methods; 1985 Oct; 82(2):189-98. PubMed ID: 3900214
[TBL] [Abstract][Full Text] [Related]
12. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
13. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
14. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
15. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Field EJ; Caspary EA; Smith KS
Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
[TBL] [Abstract][Full Text] [Related]
16. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Hoffmann W; Werner W; Steiner R; Kaufmann R
Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
[TBL] [Abstract][Full Text] [Related]
18. [Discrimination of nonspecific effects in the macrophage-electrophoretic-mobility test using dimethyl sulfoxide].
Wagner H; Irmscher J; Kotzsch M; Grossmann H; Müller M
Biomed Biochim Acta; 1983; 42(1):129-37. PubMed ID: 6192810
[TBL] [Abstract][Full Text] [Related]
19. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
[TBL] [Abstract][Full Text] [Related]
20. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M
Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
